iTraX Simplifies Outsourcing of Pre-clinical Safety Studies for AstraZeneca16 October 2017
Learn how the effective outsourcing of safety studies can be greatly simplified. Use of iTraX is shown to be key to project managing an industry-wide challenge in outsourced study tracking.
In a new DDT feature article highlighting iTraX, AstraZeneca reports increased R&D efficiencies and cost savings from the management of safety studies which are delivered through external partners. All the partners cite benefits of increased transparency and collaboration leading to improved study delivery.
Conducting studies through multiple partners requires efficient co-ordination for their set-up, planning, design, and delivery. iTraX was shown to be a preferred tool in managing this complex process, making key contributions to the overall simplification of the original process